Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys

Metabolism: Clinical and Experimental

Volumn 47, Issue 8, 1998, Pages 947-954

  Litwak, Kenneth N ^a   Cefalu, William T ^a   Wagner, Janice D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMORAL ARTERY; GLYCOSYLATION; HYPERGLYCEMIA; LIPOPROTEIN METABOLISM; MALE; MONKEY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

EID: 0031903340     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90349-3     Document Type: Article

References (45)

1. Garcia MJ, McNamara PM, Gordon T, et al: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105-111, 1974
2. Jarrett RJ, McCartney P, Keen H: The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
3. Bierman EL: Atherogenisis in diabetes. Arterioscler Thromb 12:647-656, 1992
4. Fuller JH, Shipley MJ, Rose G, et al: Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study. Br Med J 287:867-870, 1983
5. Pyörälä K, Laakso M, Uusitupa M: Diabetes and atherosclerosis: An epidemiologic view. Diabetes Metab Rev 3:463-524, 1987
6. Kuusisto J, Mykkänen L, Pyörälä K, et al: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43:960-967, 1994
7. Steinbrecher UP, Witztum JL: Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33:130-134, 1983
8. Witztum JL, Mahoney EM, Branks MJ, et al: Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283-291, 1982
9. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1320, 1988
10. Schmidt AM, Hori O, Chen JX, et al: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995
11. Huijberts MS, Wolffenbuttel BH, Crijns FR: Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia 37:10-14, 1994
12. Klein RL, Laimins M, Lopes-Virella MF: Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type 1 diabetic patients and nondiabetic subjects. Diabetes 44:1093-1098, 1995
13. Sasaki J, Cottom GL: Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 713:199-207, 1982
14. Kortlandt W, Benschop C, van Rijn HJM, et al: Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus. Diabetologia 35:202-207, 1992
15. Nordestgaard BG, Zilversmit DB: Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits: Differences in intimal clearance explained by size differences. Arteriosclerosis 9:176-183, 1989
16. Howard BV, Abbott WGH, Beltz WF, et al: Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism 36:870-877, 1987
17. Kaplan JR, Adams MR, Anthony MS, et al: Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler Thromb Vasc Biol 15:2094-2100, 1995
18. Litwak KN, Cefalu WT, Wagner JD: Streptozotocin-induced diabetes mellitsu in cynomolgus monkeys: Changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab Anim Sci 48:172-178, 1998
19. Cefalu WT, Wagner JD, Bell-Farrow AD: Role of glycated proteins in detecting and monitoring diabetes in cynomolgus monkeys. Lab Anim Sci 43:73-76, 1993
20. Allain CC, Poon LS, Chan CSG, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:40-475, 1974
21. Lipid Research Clinics Program: Manual of Laboratory Operations, vol 1: Lipid and Lipoprotein Analysis. US Department of Health, Education, and Welfare Publication No. (NIH) 75-628. Washington DC, US Government Printing Office, 1974 (revised 1982)
22. Fossati P, Principe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077-2080, 1982
23. Wagner JD, Zhang L, William JK, Register TC, et al: Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 16:1473-1480, 1996
24. Lowry OH, Rosenbrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
25. Wagner JD, Bagdade JD, Litwak KN, et al: Increased glycation of plasma lipoproteins in diabetic cynomolgus monkeys. Lab Anim Sci 46:31-35, 1996
26. Otvos JD, Jeyarajah EJ, Bennett DW, et al: Development of a proton nuclear resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38:1632-1638, 1992
27. Pittman RC, Carew TE, Glass CK, et al: A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem J 212:791-800, 1983
28. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 224:497-509, 1957
29. Carr TP, Andresen CJ, Rudel LL: Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem 26:39-42, 1993
30. Clarkson TB, Prichard RW, Morgan TM, et al: Remodeling of coronary arteries in human and nonhuman primates. JAMA 271:289-294, 1994
31. E(carboxymethyl)lysine and pentosidine in rat skin. J Gerontol Biol Sci 50:B337-B341, 1995
32. Stegemann H, Stalder K: Determination of hydroxyproline. Clin Chim Acta 18:267-273, 1967
33. Maekawa T, Rathinasamy TK, Altman KI, et al: Changes in collagen with age-I. The extraction of acid soluble collagen from the skin of mice. Exp Gerontol 5:177-186, 1970
34. Harano Y, Kojima H, Kosugi K, et al: Hyperlipidemia and atherosclerosis in experimental insulinopenic diabetic monkeys. Diabetes Res Clin Prac 16:163-173, 1992
35. Lehner NDM, Clarkson TB, Lofland HB: The effect of insulin deficiency, hypothyroidism, and hypertension on atherosclerosis in the squirrel monkey. Exp Mol Pathol 15:230-244, 1971
36. 125I-tyramine cellobiose-labeled low density lipoprotein is greater in the atherosclerosis-susceptible region of white carneau pigeon aorta and further enhanced once atherosclerotic lesions develop. Arterioscler Thromb 12:446-460, 1992
37. Wiklund O, Witztum JL, Carew TE, et al: Turnover and tissue sites of degradation of glucosylated low density lipoprotein in normal and immunized rabbits. J Lipid Res 28:1098-1109, 1987
38. Edwards IJ, Wagner JD, Litwak KN, et al: Glycation of plasma low density lipoproteins leads to increased interaction with arterial proteoglycans. Diabetes 46:45A, 1997 (suppl 1)
39. Lee WK, Bell J, Kilpatrick E, et al: Collagen-linked fluoresence in human atherosclerotic plaques. Atherosclerosis 98:219-227, 1993
40. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41:67-73, 1992 (Suppl 2)
41. Austin MA, Breslow JL, Hennekens CHD, et al: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
42. Rhees RW, Wilson CT, Heminger RW: Influence of streptozotocin diabetes and insulin therapy on plasma corticosterone levels in male rats. Horm Metab Res 15:353-354, 1983
43. Valdes CT, Elkind-Hirsch KE, Rogers DG: Diabetes-induced alterations of reproductive and adrenal function in the female rat. Endocrinology 51:406-412, 1990
44. Steinbrecher UP, Witztum JL, Parthasarathy S, et al: Decrease in reative amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 7:135-143, 1987
45. Cefalu WT, Wagner JD: Aging and atherosclerosis in human and nonhuman primates. Age 20:15-28, 1997